Condition: Oligometastatic Disease · Sponsor: IRCCS San Raffaele
This is a randomised prospective monoinstitutional study comparing radiosurgery at a total dose up to 24 Gy to five fraction stereotactic radiotherapy with simultaneous integrated boost (SIB) up to 50 Gy for the treatment of bone metastases in oligometastatic cancer treated with radical intent. At the end of the first 12 months from the start of the study an interim analysis will be performed taking into account all major endpoints for an initial evaluation of the study , with only an observational purpose, without subsequent protocol changes.
This description comes directly from the study's public registry record.
Nadia G Di Muzio, Prof. · +390226437643 · dimuzio.nadia@hsr.it
Andrei Fodor, MD · +390226437634 · fodor.andrei@hsr.it
Always discuss trial participation with your own doctor first.
| San Raffaele Scientific Institute | Milan, MI, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05679427